Acquiring Company
Dr Ashleys Limited
Acquired Company
Impact Biomedical
Description
Dr Ashleys USA Inc. has successfully completed its merger with Impact Biomedical Inc., as outlined in the Merger Agreement. The transaction resulted in the appointment of new directors and the establishment of the surviving corporation. This merger is set to enhance Dr Ashleys USA Inc.'s capabilities in the biomedical sector. Further restructuring of the corporate governance was also implemented at the Effective Time.
Quick answer
Dr Ashleys Limited is acquiring Impact Biomedical, announced November 18, 2026. Dr Ashleys Limited is based in Hong Kong SAR, China.
- How much did Dr Ashleys Limited pay for Impact Biomedical?
- The deal value was not disclosed.
- What does Dr Ashleys Limited do?
- Dr Ashleys Limited is a global pharmaceutical company focused on innovation in drug development.
- Where are Dr Ashleys Limited and Impact Biomedical based?
- Dr Ashleys Limited is based in Hong Kong SAR, China. Impact Biomedical is based in New York, United States.
- Who are the decision-makers at Dr Ashleys Limited?
- Fundz holds 4 contacts at Dr Ashleys Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Gedeon Richter to acquire Mayne Pharma at $6.40/share (November 16, 2026)
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- Nuformix proposes merger with Biovara (November 11, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Charles River Laboratories to Acquire Bioanalysis and DMPK Operations from Frontage Holdings (November 9, 2026)
Who to call at Dr Ashleys Limited, and when
When Dr Ashleys Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Dr Ashleys Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dr Ashleys Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dr Ashleys Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dr Ashleys Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Impact Biomedical?
Impact Biomedical was acquired by Dr Ashleys Limited, based in Hong Kong SAR. The deal was reported on November 18, 2026. Dr Ashleys Limited is a global pharmaceutical company focused on innovation in drug development. The company has extensive experience in bringing pharmaceutical treatments to market. Dr Ashleys Limited is privately held and operates in Biotechnology.
When did Dr Ashleys Limited acquire Impact Biomedical?
Dr Ashleys Limited's acquisition of Impact Biomedical was reported on November 18, 2026. Dr Ashleys USA Inc. has successfully completed its merger with Impact Biomedical Inc., as outlined in the Merger Agreement. The transaction resulted in the appointment of new directors and the establishment of the surviving corporation. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Impact Biomedical do?
Impact Biomedical Inc. is a company listed on NYSE American under the ticker IBO. Its stockholders are scheduled to vote on November 13, 2026 on approving the merger and share exchange agreement with Zoar Limited. It is privately held, operating in Biotechnology, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.